Pharmaceutical Drugs

Featured

Although pharmaceutical drugs on the whole greatly improve patient outcomes and quality of life when used as prescribed, they are not without their complications. RAND research on pharmaceuticals examines their safety and effectiveness, relevant health economics issues, prescription drug abuse, challenges related to access and adherence, and pharmaceutical regulatory policy.

  • Scientist working with a diagnostics kit to detect the virus that causes COVID-19, photo by anyaivanova/Getty Images

    Report

    How to Best Enable Pharma Innovation Beyond the COVID-19 Crisis

    May 26, 2020

    Innovating in response to public health challenges like COVID-19 does not always align well with pharmaceutical industry commercial models or shareholder expectations. More sustainable and scalable ways of incentivizing innovation in response to infectious disease threats are needed.

  • A woman from Minnesota holds up her U.S. bottle of NovoLog insulin and a Canadian box of NovoRapid, which she bought at a pharmacy in Ontario, Canada, June 29, 2019, photo by Geoff Robins/The Canadian Press via AP

    Essay

    The Astronomical Price of Insulin Hurts American Families

    Jan 6, 2021

    More than 30 million Americans have diabetes, and nearly a quarter of them use insulin to manage their symptoms and prevent life-threatening complications. The price they have to pay for insulin is more than ten times higher than the average prices in 32 other countries combined.

Explore Pharmaceutical Drugs

Research conducted by